REACT-2 Round 5: increasing prevalence of SARS-CoV-2 antibodies demonstrate impact of the second wave and of vaccine roll-out in England
View ORCID ProfileHelen Ward, View ORCID ProfileGraham Cooke, View ORCID ProfileMatthew Whitaker, View ORCID ProfileRozlyn Redd, View ORCID ProfileOliver Eales, Jonathan C Brown, Katharine Collet, Emily Cooper, View ORCID ProfileAnna Daunt, Kathryn Jones, Maya Moshe, View ORCID ProfileMichelle Willicombe, View ORCID ProfileSophie Day, View ORCID ProfileChristina Atchison, View ORCID ProfileAra Darzi, View ORCID ProfileChristl A Donnelly, View ORCID ProfileSteven Riley, View ORCID ProfileDeborah Ashby, View ORCID ProfileWendy S Barclay, View ORCID ProfilePaul Elliott
doi: https://doi.org/10.1101/2021.02.26.21252512
Helen Ward
1School of Public Health, Imperial College London, UK
2MRC Centre for Global infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, UK
4Imperial College Healthcare NHS Trust, UK
5National Institute for Health Research Imperial Biomedical Research Centre, UK
Graham Cooke
3Department of Infectious Disease, Imperial College London, UK
4Imperial College Healthcare NHS Trust, UK
5National Institute for Health Research Imperial Biomedical Research Centre, UK
Matthew Whitaker
1School of Public Health, Imperial College London, UK
Rozlyn Redd
1School of Public Health, Imperial College London, UK
Oliver Eales
1School of Public Health, Imperial College London, UK
2MRC Centre for Global infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, UK
Jonathan C Brown
3Department of Infectious Disease, Imperial College London, UK
4Imperial College Healthcare NHS Trust, UK
Katharine Collet
1School of Public Health, Imperial College London, UK
Emily Cooper
1School of Public Health, Imperial College London, UK
Anna Daunt
Kathryn Jones
1School of Public Health, Imperial College London, UK
5National Institute for Health Research Imperial Biomedical Research Centre, UK
Maya Moshe
3Department of Infectious Disease, Imperial College London, UK
Michelle Willicombe
3Department of Infectious Disease, Imperial College London, UK
Sophie Day
1School of Public Health, Imperial College London, UK
5National Institute for Health Research Imperial Biomedical Research Centre, UK
Christina Atchison
1School of Public Health, Imperial College London, UK
Ara Darzi
4Imperial College Healthcare NHS Trust, UK
6Institute of Global Health Innovation at Imperial College London, UK
Christl A Donnelly
1School of Public Health, Imperial College London, UK
2MRC Centre for Global infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, UK
7Department of Statistics, University of Oxford, UK
Steven Riley
1School of Public Health, Imperial College London, UK
2MRC Centre for Global infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, UK
Deborah Ashby
1School of Public Health, Imperial College London, UK
Wendy S Barclay
3Department of Infectious Disease, Imperial College London, UK
Paul Elliott
1School of Public Health, Imperial College London, UK
4Imperial College Healthcare NHS Trust, UK
5National Institute for Health Research Imperial Biomedical Research Centre, UK
8MRC Centre for Environment and Health, School of Public Health, Imperial College London, UK
9Health Data Research (HDR) UK London at Imperial College
10UK Dementia Research Institute at Imperial College
Data Availability
The data analysed or used, or both, in this study are not publicly available owing to governance restrictions.
Posted March 01, 2021.
REACT-2 Round 5: increasing prevalence of SARS-CoV-2 antibodies demonstrate impact of the second wave and of vaccine roll-out in England
Helen Ward, Graham Cooke, Matthew Whitaker, Rozlyn Redd, Oliver Eales, Jonathan C Brown, Katharine Collet, Emily Cooper, Anna Daunt, Kathryn Jones, Maya Moshe, Michelle Willicombe, Sophie Day, Christina Atchison, Ara Darzi, Christl A Donnelly, Steven Riley, Deborah Ashby, Wendy S Barclay, Paul Elliott
medRxiv 2021.02.26.21252512; doi: https://doi.org/10.1101/2021.02.26.21252512
REACT-2 Round 5: increasing prevalence of SARS-CoV-2 antibodies demonstrate impact of the second wave and of vaccine roll-out in England
Helen Ward, Graham Cooke, Matthew Whitaker, Rozlyn Redd, Oliver Eales, Jonathan C Brown, Katharine Collet, Emily Cooper, Anna Daunt, Kathryn Jones, Maya Moshe, Michelle Willicombe, Sophie Day, Christina Atchison, Ara Darzi, Christl A Donnelly, Steven Riley, Deborah Ashby, Wendy S Barclay, Paul Elliott
medRxiv 2021.02.26.21252512; doi: https://doi.org/10.1101/2021.02.26.21252512
Subject Area
Subject Areas
- Addiction Medicine (404)
- Allergy and Immunology (713)
- Anesthesia (208)
- Cardiovascular Medicine (2972)
- Dermatology (254)
- Emergency Medicine (446)
- Epidemiology (12823)
- Forensic Medicine (12)
- Gastroenterology (833)
- Genetic and Genomic Medicine (4625)
- Geriatric Medicine (424)
- Health Economics (733)
- Health Informatics (2944)
- Health Policy (1074)
- Hematology (394)
- HIV/AIDS (935)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (476)
- Neurology (4420)
- Nursing (238)
- Nutrition (653)
- Oncology (2298)
- Ophthalmology (653)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (284)
- Palliative Medicine (85)
- Pathology (503)
- Pediatrics (1201)
- Primary Care Research (503)
- Public and Global Health (7013)
- Radiology and Imaging (1549)
- Respiratory Medicine (922)
- Rheumatology (446)
- Sports Medicine (386)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (185)